The first co-packaged mifepristone and misoprostol indicated for the medical termination of a developing intra-uterine pregnancy with a gestational age up to 63 days amenorrhea.

The Combi-Pack is marketed in Australia as MS 2-Step™ and in Canada as Mifegymiso®.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Linepharma International. Not all products or indications are licensed in every country and may be subject to further local variations. For addtional information please refer to the summary of product characteristic. For advice on medical issues please consult your local medical practitioner.

Misoprostol is a prostaglandin analogue that triggers uterine contractions and relaxation of the cervix.

Please note that product information presented on this website is intended only as a brief summary for the visitor’s convenience in relation to the activities of the Linepharma International. Not all products or indications are licensed in every country and may be subject to further local variations. For addtional information please refer to the summary of product characteristic. For advice on medical issues please consult your local medical practitioner.